Document is current
Any future updates will be listed below
-
Authors
Xu, Mengdan
Zhang, Dongmei
Yang, Menghuan
Wu, Wenyu
-
Funding
Funding for this research was provided by:
The Science and Technology Innovation Project of Guangdong Medical Products Administration (No.2022ZDZ06, No.2024ZDZ10)
Philosophy and Social Science Planning Project of Guangdong Province in 2023 (No. GD23SQGL01)
Key Laboratory for Pharmacovigilance Data Research and Evaluation (2021ZDB01)
Guangdong Public Drug Safety Risk Management Research Base (2021JDB01)
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 27 August 2024
First Online: 2 September 2024
Declarations
:
: The study protocol was approved (03, 2023) by the Medical Ethics Review Committee of the School of Public Health within Guangdong Pharmaceutical University (Guangdong, China). Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare no competing interests.
